We have qualitatively reviewed this strategy and reaffirmed its Above Average People and Above Average Process ratings. Vanguard Long-Term Corporate Bond ETF boasts a well-diversified, market-value-weighted portfolio and a rock-bottom fee. It’s a solid option for long-term U.S. investment-grade corporate bonds. The following text is from Feb. 27, 2023.
Vanguard Long-Term Corporate Bd ETF VCLT
- NAV / 1-Day Return 81.01 / +0.05 %
- Total Assets 13.9 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.040%
- Distribution Fee Level —
- Share Class Type —
- Category Long-Term Bond
- Credit Quality / Interest Rate Sensitivity Medium/Extensive
- Min. Initial Investment —
- Status Open
- TTM Yield 4.82%
- Effective Duration 12.71 years
USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 1:01 AM GMT+0
Morningstar’s Analysis VCLT
Will VCLT outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 2.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Mktliq 12/31/2049 | 0.53 | 72.8 Mil | Cash and Equivalents |
Anheuser-Busch Companies LLC / Anheuser-Busch InBev Worldwide Inc | 0.35 | 47.4 Mil | Corporate |
CVS Health Corp | 0.28 | 37.6 Mil | Corporate |
Pfizer Investment Enterprises Pte Ltd. | 0.26 | 35.2 Mil | Corporate |
Goldman Sachs Group, Inc. | 0.25 | 33.8 Mil | Corporate |
Anheuser-Busch Companies LLC / Anheuser-Busch InBev Worldwide Inc | 0.24 | 33.1 Mil | Corporate |
AT&T Inc | 0.24 | 32.3 Mil | Corporate |
WarnerMedia Holdings Inc. | 0.23 | 31.8 Mil | Corporate |
AT&T Inc | 0.23 | 30.9 Mil | Corporate |
CVS Health Corp | 0.21 | 29.0 Mil | Corporate |